Clinical Trial Update: Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated different tenofovir/emtricitabine regimens for HIV PrEP in transgender women to identify an optimal regimen based on safety and pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Johns Hopkins University | Conditions: HIV Prevention | Phase 1 | Status: COMPLETED